BioCentury
ARTICLE | Clinical News

DPP HIV 1/2 Screen: Completed pivotal trial enrollment

April 23, 2012 7:00 AM UTC

Chembio completed enrollment of about 3,000 patients in a U.S. pivotal trial evaluating its DPP HIV 1/2 Screen. The trial supports the third and final module of Chembio's PMA to FDA. Chembio expects t...